Cross-presentation of tumor antigens by bone marrow derived antigen-presenting cells (APCs) is the dominant mechanism in tolerance induction to B-cell lymphomas.

被引：0
|
作者：
Sotomayor, EM
Borrello, I
Rattis, FM
Abrams, J
Levitsky, HI
机构：
[1] H Lee Moffit Canc Ctr & Res Inst, Tampa, FL USA
[2] Johns Hopkins Oncol Ctr, Baltimore, MD USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2795
引用
收藏
页码：629A / 629A
页数：1
相关论文
共 48 条
  • [41] TUMOR-ASSOCIATED ANTIGEN-PRESENTING CELLS (APCS) ARE DEFICIENT IN EXPRESSION OF T-CELL COSTIMULATORY MOLECULES B7-1 (CD80) AND B7-2 (CD86)
    NICKOLOFF, BJ
    BURG, G
    NESTLE, FO
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (04) : 646 - 646
  • [42] Thymic Dominant Tolerance of Type 1 Diabetes: Essential Roles of Insulin Expression in Bone Marrow-Derived Antigen Presenting Cells in Maintaining Peripheral Self-Tolerance to Islet Beta-Cells, but Not for Central Negative Selection
    Grupillo, Maria
    He, Jing
    Sisino, Giorgia
    Flounlacker, Joseph
    Wong, Catarina
    Lakomy, Robert
    Styche, Alexis
    Hou, Ling
    Owens, Gregory
    Rudert, William A.
    Trucco, Massimo
    Fan, Yong
    DIABETES, 2011, 60 : A72 - A72
  • [43] Characterization of murine dendritic cell line JAWS II and primary bone marrow-derived dendritic cells in Chlamydia muridarum antigen presentation and induction of protective immunity
    Jiang, Xiaozhou
    Shen, Caixia
    Rey-Ladino, Jose
    Yu, Hong
    Brunham, Robert C.
    INFECTION AND IMMUNITY, 2008, 76 (06) : 2392 - 2401
  • [44] INDUCTION OF CLASS-I AND CLASS-II MHC ANTIGEN EXPRESSION ON MURINE BONE MARROW-DERIVED MACROPHAGES BY IL-4 (B-CELL STIMULATORY FACTOR-I)
    STUART, PM
    ZLOTNIK, A
    WOODWARD, JG
    JOURNAL OF IMMUNOLOGY, 1988, 140 (05): : 1542 - 1547
  • [45] The Role of the Microenvironment for CLL Proliferation and Survival: Gene Expression Profiling of Leukemic Cells Derived from Blood, Bone Marrow and Lymph Nodes Reveals the B-Cell Receptor and NF-κB as Dominant Signaling Pathways
    Herishanu, Yair
    Vire, Berengere
    Liu, Delong
    Gibellini, Federica
    Marti, Gerald E.
    White, Therese
    Njuguna, Ndegwa
    Raghavachari, Nalini
    Liu, Poching
    Pittaluga, Stefania
    Munson, Peter J.
    Wilson, Wyndham H.
    Wiestner, Adrian
    BLOOD, 2008, 112 (11) : 139 - 139
  • [46] Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen-specific CTL response with antitumor activity in vitro
    Correale, P
    Cusi, MG
    Del Vecchio, MT
    Aquino, A
    Prete, S
    Tsang, KY
    Micheli, L
    Nencini, C
    La Placa, M
    Montagnani, F
    Terrosi, C
    Caraglia, M
    Formica, V
    Giorgi, G
    Bonmassar, E
    Francini, G
    JOURNAL OF IMMUNOLOGY, 2005, 175 (02): : 820 - 828
  • [47] CROSS-SPECIES TRANSPLANTATION TOLERANCE - RAT BONE-MARROW DERIVED CELLS CAN CONTRIBUTE TO THE LIGAND FOR NEGATIVE SELECTION OF MOUSE T-CELL RECEPTOR-V-BETA IN CHIMERAS TOLERANT TO XENOGENEIC ANTIGENS (MOUSE + RAT -] MOUSE)
    ILDSTAD, ST
    VACCHIO, MS
    MARKUS, PM
    HRONAKES, ML
    WREN, SM
    HODES, RJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (01): : 147 - 155
  • [48] Dendritic cell-mediated cross-presentation of antigens derived from colon carcinoma cells exposed to a highly cytotoxic multidrug regimen with gemcitabine, oxaliplatin, 5-fluorouracil, and leucovorin, elicits a powerful human antigen -specific CTL response with antitumor activity in vitro (vol 175, pg 820, 2005)
    Correale, P
    Cusi, MG
    Del Vecchio, MT
    Aquino, A
    Prete, S
    Tsang, KY
    Micheli, L
    Nencini, C
    La Placa, A
    Montagnani, F
    Terrosi, C
    Caraglia, M
    Formica, V
    Giorgi, G
    Bonmassar, E
    Francini, G
    JOURNAL OF IMMUNOLOGY, 2005, 175 (09): : 6235 - 6235
12345